ClinicalTrials.gov
public full text
Public Domain
Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
This is a Phase 1, open-label, parallel-group study to evaluate rotigotine pharmacokinetics, safety and tolerability following a single intramuscular dose of one of two different formulations of LY03003 in patients with Parkinson's disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol#1045211
- Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal#861764
- NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa#814003
- A Multiple Dose Study of LY3023703 in Healthy Participants#885614
- Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease#1088921
Record · ID 886737
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive